MedPath

Multicenter Comparative Study of the Activity of the Medial Prefrontal Cortex in Vulnerability to Depression

Completed
Conditions
Major Depression
Registration Number
NCT02171923
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Brief Summary

To examine whether the medial prefrontal cortex displays an increased activity during self-referential processing among remitted depressed patients compared to healthy controls

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
77
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
BOLD signal in the medial prefrontal cortex18 month

Each subject will have a standardized psychometric assessment (BDI-21, MADRS, STAI, RRS) in a Siemens 3T Trio for collecting voxel BOLD signal (Blood-Oxygen-Level Dependent). For each subject and each voxel, a coefficient beta relative activation will be obtained with a general linear model using the timing of presentation of stimuli and the expected signal to model the measured hemodynamic BOLD response. A main effect of condition (personal versus general) will be sought to determine the peak activation within the dorsal CMPF (defined region of interest using the Pickatlas software). The primary endpoint will be the beta coefficient on the level of activation of a sphere 10 mm in diameter centered on the peak.

Secondary Outcome Measures
NameTimeMethod
depression relapse1 year

The presence (MINI) and intensity (BDI) for possible depressive relapse will be sought from the attending psychiatrist and during telephone interviews at 6 and 12 months.

Trial Locations

Locations (1)

URC - HEGP, 20 rue Leblanc

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath